SEMA3F and neoplasm: Moreover, PI-3K, a regulator of Akt, is also deactivated by SEMA3F in tumor and ECs, suggesting that SEMA3F is a powerfull inhibitor of the PI-3K-Akt-mTOR signaling pathway (Figure 1).